Turning animal predictions of drug safety into human predictions with ARTEMIS™

ABOUT

Bridging the Gap with Advanced Toxicology

In the pharma industry drug safety assessment is outdated, contributing to 90% of drug failures. We introduce ARTEMIS™, a computational platform that bridges the animal-to-human gap leading to reliable human predictions, shorter timelines, better success rates, greater compliance, and impactful cost savings. Join us in pursuit of a brighter tomorrow.

PROJECTS

Current Flawed Approach Puts Patients At Risk

PROBLEM #1

DATA SILOING

Regulatory decisions on drug safety are made by comparing animal data in a study with animal data in that same study

PROBLEM #2

MISCHARACTERIZATION

This heavy siloing of toxicology data leads to a mischaracterization of animal findings

PROBLEM #3

INACCURATE ASSESSMENTS

This mischaracterization leads to incorrect safety assessments and big animal-to-human gaps

PROBLEM #4

WASTED RESOURCES

Big gaps mean long timelines, studies being rerun, money being wasted, and high fail rates of new drugs

PROBLEM #5

PATIENTS SUFFER

In the end, people are put at risk and patients are delayed access to new medicines

SERVICES

ARTEMIS™ un-silos animal data and connects it to the world, synergizing animal predictions of drug safety to project human toxicology

THE TEAM

ARTEMIS™ will redefine nonclinical toxicology and drug safety by closing the translational gap of animal-to-human assessments

Join Waitlist

CLIENTS

With ARTEMIS™, everyone wins.
Reach out to learn more.

Schedule Intro